Medical devices and consumables supply solutions

Velora provides integrated healthcare supply chain solutions by directly connecting international manufacturers with hospital systems and clinical facilities in the United States.

We focus on product categories with high demand and essential roles in healthcare operations, including consumables, diagnostic equipment, surgical supplies, and specialty medical products.

By eliminating unnecessary intermediary layers and establishing direct relationships with manufacturers, Velora enables hospital systems to optimize procurement costs by 15–30%, while ensuring supply chain stability and transparency.

In addition, Velora performs quality control and ensures compliance with regulatory standards in the United States, including FDA-related requirements, ensuring that all products meet safety and performance standards.

Beyond supply, Velora also supports hospital partners in optimizing procurement processes and improving overall operational efficiency.

Velora connects international manufacturers with hospital systems and clinical facilities in the United States, helping optimize cost and ensure quality.

Product Scope

• Consumables 
• Medical devices 
• Surgical supplies 
• Specialty equipment 

Value Delivered

• 15–30% cost reduction 
• FDA-compliant standards 
• Stable supply 
• Procurement optimization

International patient access solutions

Velora supports patients in Vietnam and Southeast Asia in accessing leading healthcare systems in the United States, particularly in areas requiring advanced technology and specialized expertise.

Services focus on high-value medical needs such as advanced oncology treatment, precision medicine, executive health screening, and access to clinical trial programs.

Velora accompanies patients throughout the entire treatment journey, from initial consultation, hospital matching, insurance support, visa and travel coordination, to treatment and post-treatment care.

This model not only provides direct value to patients but also creates a sustainable connection flow between international markets and healthcare systems in the United States.

Services

• Advanced oncology treatment 
• Precision medicine 
• Executive health screening 
• Clinical trials 

Patient Journey

1. Consultation 
2. Hospital matching 
3. Insurance 
4. Visa and travel 
5. Treatment 
6. Post-treatment care

Technology transfer and pharmaceutical collaboration

Velora connects U.S. pharmaceutical companies with manufacturing partners in Asia.

Velora serves as a strategic bridge between U.S. pharmaceutical companies and manufacturing partners in Asia, facilitating technology transfer and expanding production capabilities.

Collaboration models include formulation and manufacturing process transfer, market-specific exclusive licensing, co-development, and distribution system development.

For U.S. pharmaceutical companies, Velora enables expansion into Asian markets, optimizes manufacturing costs, and shortens time-to-market.

For manufacturers in Vietnam, Velora provides access to advanced technologies, enhances production standards, and enables deeper participation in the global pharmaceutical value chain.

Model

• Technology transfer 
• Licensing 
• Distribution 
• Co-development 

Value

For U.S. partners:

• Market expansion 
• Cost optimization 
• Accelerated commercialization 

For international partners:

• Access to technology 
• Upgrading production standards 
• Participation in the global value chain 

Velora is built on an integrated model in which activities do not operate independently but reinforce one another, forming a continuous growth cycle.

• Supply chain activities create relationships with hospital systems.
  
• Hospital relationships generate international patient flows.
  
• Patient flows expand pharmaceutical partnership opportunities.

This structure allows Velora not only to generate revenue across multiple layers but also to build a sustainable competitive advantage over time.